Review article · 2012 · Open access
Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells
Regenerative Medicine, 7(5), 713–720 · Published 1 September 2012 · DOI 10.2217/rme.12.51
In brief
“Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells” is a 2012 review article by Paul S. Knoepfler, published in Regenerative Medicine. OpenAlex counts 26 citations as of 21 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).
- Citations
- 26
- Most cited in
- 2013 (5)
- Field-weighted impact
- 0.21
- References
- 51
- Authors
- 1
Abstract
The production of human induced pluripotent stem cells (hiPSCs) has greatly expanded the realm of possible stem cell-based regenerative medicine therapies and has particularly exciting potential for autologous therapies. However, future therapies based on hiPSCs will first have to address not only similar regulatory issues as those facing human embryonic stem cells with the US FDA and international regulatory agencies, but also hiPSCs have raised unique concerns as well. While the first possible clinical use of hiPSCs remains down the road, as a field it would be wise for us to anticipate potential roadblocks and begin formulating solutions. In this article, I discuss the potential regulatory issues facing hiPSCs and propose some potential changes in the direction of the field in response.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Knoepfler, P. S. (2012). Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells. Regenerative Medicine, 7(5), 713–720. https://doi.org/10.2217/rme.12.51
MLA 9
Knoepfler, Paul S. “Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells.” Regenerative Medicine, vol. 7, no. 5, 2012, pp. 713–720. https://doi.org/10.2217/rme.12.51.
Chicago
Knoepfler, Paul S. 2012. “Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells.” Regenerative Medicine 7 (5): 713–720. https://doi.org/10.2217/rme.12.51.
Harvard
Knoepfler, P. S. (2012) ‘Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells’, Regenerative Medicine, 7(5), pp. 713–720. doi:10.2217/rme.12.51.
IEEE
P. S. Knoepfler, “Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells,” Regenerative Medicine, vol. 7, no. 5, pp. 713–720, 2012, doi: 10.2217/rme.12.51.
BibTeX
@article{knoepfler2012anticipated,
title = {{Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells}},
author = {Knoepfler, Paul S.},
journal = {Regenerative Medicine},
year = {2012},
volume = {7},
number = {5},
pages = {713--720},
doi = {10.2217/rme.12.51},
url = {https://doi.org/10.2217/rme.12.51}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2013 | 5 | |
| 2014 | 3 | |
| 2016 | 2 | |
| 2017 | 5 | |
| 2019 | 2 | |
| 2021 | 1 | |
| 2023 | 3 | |
| 2024 | 2 | |
| 2025 | 2 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.21: it has been cited 0.21 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- human induced pluripotent stem cells
- stem cell regulation
- clinical translation
- autologous cell therapy
- FDA regulation
- regulatory challenges
- stem cell therapy
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Knoepfler, P. S. (2012). Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells. Regenerative Medicine, 7(5), 713–720. https://doi.org/10.2217/rme.12.51
How many times has this paper been cited?
26 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.
Who wrote this paper?
Paul S. Knoepfler.
What is the DOI of this paper?
10.2217/rme.12.51, permanently at https://doi.org/10.2217/rme.12.51. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.